# Trade Mark Journal No.2025/052 26 December 2025

## WO0000001891094 (5,42)

Office of origin: Benelux Office for Intellectual Property (BOIP)

Date of International Registration:23 September 2025
Date of designation in the UK: 23 September 2025

International priority date claimed: 28 March 2025 (Benelux Office for Intellectual Property (BOIP)) (1522090)

Class 5
  Pharmaceutical preparations; pharmaceuticals and medicines for the treatment and prevention of neurological disorders; pharmaceuticals and medicines for the treatment and prevention of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of eye diseases and conditions; pharmaceuticals and medicines for the treatment and prevention of bone disorders and conditions, therapeutic preparations for the management of retinal disorders; injectable pharmaceuticals for the treatment of ocular diseases and neurological disorders.
Class 42
  Medical and pharmacological research services; pharmaceutical research and development of pharmaceuticals and medicines; pharmaceutical research and development of pharmaceutical products and medicines for the treatment and prevention of neurological disorders, eye diseases and bone disorders.

Neuvasq Biotechnologies, naamloze vennootschap

Representative: Brantsandpatents BV, Pauline van Pottelsberghelaan 24, B-9051 Ghent, BELGIUM